Shenyang Northern Hospital
Clinical trials sponsored by Shenyang Northern Hospital, explained in plain language.
-
Heart attack patients may get shorter blood thinner course based on new risk tool
Disease control Recruiting nowThis study tests whether a risk score (OPT-CAD) can safely guide when to switch from two blood thinners to just one after a heart attack and stent placement. About 3,490 adults with acute coronary syndrome will be assigned to stop one blood thinner at either 1 or 3 months based o…
Phase: NA • Sponsor: Shenyang Northern Hospital • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
AI app could save heart attack patients when time is critical
Disease control Recruiting nowThis study tests whether a smartphone app powered by artificial intelligence can help doctors give clot-busting medicine faster to people having a severe heart attack (STEMI) when immediate angioplasty isn't available. About 3,356 adults in China will take part. The goal is to se…
Phase: NA • Sponsor: Shenyang Northern Hospital • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
10,000 heart patients enrolled to uncover best treatments
Knowledge-focused Recruiting nowThis study follows 10,000 adults hospitalized with confirmed or suspected coronary heart disease. Researchers will collect detailed health data to see which real-world treatments lead to better outcomes, such as fewer heart attacks or strokes. The goal is to find ways to improve …
Sponsor: Shenyang Northern Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 04:33 UTC